Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
GUIAS NICE PARA CA DE MAMA AVANZADO

GUIAS NICE PARA CA DE MAMA AVANZADO

Ratings: (0)|Views: 4|Likes:
Published by Ernesto Gil Deza

More info:

Published by: Ernesto Gil Deza on Mar 18, 2011
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

03/18/2011

pdf

text

original

 
 Issue date: February 2009
NICE clinical guideline 81
Developed by the National Collaborating Centre for Cancer
Advanced breast cancer
Diagnosis and treatmentThis guideline updates and replaces NICE technologyappraisal guidance 62 (capecitabine), 54 (vinorelbine)and 30 (taxanes)
 
 
NICE clinical guideline 81Advanced breast cancer: diagnosis and treatmentOrdering information
You can download the following documents from www.nice.org.uk/CG081 
 
The NICE guideline (this document) – all the recommendations.
A quick reference guide – a summary of the recommendations forhealthcare professionals.
‘Understanding NICE guidance’ – a summary for patients and carers.
The full guideline – all the recommendations, details of how they weredeveloped, and reviews of the evidence they were based on.For printed copies of the quick reference guide or ‘Understanding NICEguidance’, phone NICE publications on 0845 003 7783 or emailpublications@nice.org.uk and quote:
N1794 (quick reference guide)
N1795 (‘Understanding NICE guidance’).NICE clinical guidelines are recommendations about the treatment and care ofpeople with specific diseases and conditions in the NHS in England andWales.This guidance represents the view of NICE, which was arrived at after carefulconsideration of the evidence available. Healthcare professionals areexpected to take it fully into account when exercising their clinical judgement.However, the guidance does not override the individual responsibility ofhealthcare professionals to make decisions appropriate to the circumstancesof the individual patient, in consultation with the patient and/or guardian orcarer, and informed by the summary of product characteristics of any drugsthey are considering.Implementation of this guidance is the responsibility of local commissionersand/or providers. Commissioners and providers are reminded that it is theirresponsibility to implement the guidance, in their local context, in light of theirduties to avoid unlawful discrimination and to have regard to promotingequality of opportunity. Nothing in this guidance should be interpreted in a waythat would be inconsistent with compliance with those duties.
National Institute for Health and Clinical Excellence
MidCity Place71 High HolbornLondon WC1V 6NAwww.nice.org.uk
© National Institute for Health and Clinical Excellence, 2009. All rights reserved. This materialmay be freely reproduced for educational and not-for-profit purposes. No reproduction by orfor commercial organisations, or for commercial purposes, is allowed without the expresswritten permission of NICE.
 
 
 
Contents
1
2
3
4
5
6
7

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->